{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2004"],"condition":["Rectal Neoplasms","Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"disease":["Rectal Neoplasms","Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2010713"],"location":["United States","Former Serbia and Montenegro"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Clinical Trial in Patients With Metastatic Colorectal Cancer","description":"The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.","dates":{"creation":"2004-04-15"},"accession":"2010713","cross_references":{"ClinicalTrials___gov":["NCT00081627"]}}